Eileen Beckman, RN

Cincinnati Children's Hospital Medical CenterCincinnati, Ohio - 45229-3039 |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS2
- SINCE2009

Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease
August 2009 - November 2011
Fabry Disease
Placebo
Migalastat Hydrochloride



